-
UPCC 02818: A Phase I/IB Study of Avelumab in Combination with Gemcitabine for Advanced Renal Cell Carcinoma with Sarcomatoid ...
This study is being done because doctors are trying to develop better methods for treating kidney cancer that has spread ...
Exact
Phase 
-
HCC Cholate- Hepatic functional deterioration after radiation therapy for hepatocellular carcinoma measured by hepatic cholate clearance
In this study, subjects diagnosed with liver cancer undergo the HepQuant SHUNT diagnostic assay as a means to determine liver ...
Exact
Phase
-
UPCC 15217: A Pivotal Trial of ARQ 087 in Subjects with FGFR2 Gene Fusion Positive Inoperable or Advanced Intrahepatic Cholangiocarcinoma
The main purpose of this study is to find out if the study drug ARQ 087 is safe and effective ...
Exact
Phase 
-
UPCC 35217: A Phase 1B/2 Open label study of Niraparib plus either Ipilimumab or Nivolumab in patients with advanced ...
The main purpose of this study is to look at the effectiveness, safety, and anti-tumor activity (preventing growth of the ...
Exact
Phase 
-
Quality Improvement Assessment for Patient-Centered Community Health Worker Intervention
The purpose of the IMPaCT Transitions program is to help low-income general medicine patients who have been cared for at ...
Exact
-
“The Shift Worker’s Microbiome”
We are looking for healthy males, age 40-59 years old, non-smoking un-medicated who work the "shift-work" schedule (>3 shifts per ...
Exact
-
A Phase 2 Multicenter, Open Label, Randomized Study of Two Titration Regimens of Oral CXA-10 in Subjects with Primary Focal ...
Primary FSGS is a progressive disease that causes the kidneys to scar, to leak protein into the urine and may ...
Exact
Phase
-
Evaluating in vivo PARP-1 expression with 18F-FluorThanatrace positron emission tomography (PET/CT) in Pancreatic Cancer
This is a pilot study in patients with histologically proven pancreatic adenocarcinoma who have demonstrated at least stable disease following ...
Free text
Phase
-
UPCC 28218: A Phase II Study of Nivolumab and Ipilimumab in Mucinous Colorectal and Appendiceal Tumors
This is a single-arm phase II study of twenty-one subjects with mucinous adenocarcinoma of the colon, rectum, or appendix with ...
Free text
Phase
-
UPCC 09220: Phase II Study of Telomelysin (OBP-301) in Combination with Pembrolizumab in Esophagogastric Adenocarcinoma
The purpose of this study is to test the effects of the research study drug Telomelysin (OBP-301) in combination with ...
Free text
Phase
Showing - of trials